Jan Tjibbe Stelwagen
Netherlands
Jan Tjibbe Stelwagen is a Dutch poker player and police confrontation specialist from Friesland. He has been active in European poker tournaments, notably reaching the final three of a €1,000 event in 2011. Outside poker, he has worked as a Vakspecialist Confrontaties at Politie since 1987.
Early Life and Career
Jan Tjibbe Stelwagen, hailing from Friesland, Netherlands, has balanced a career in law enforcement with poker. Since 1987, he has served as a Vakspecialist Confrontaties at the Dutch police, specializing in witness identification and confrontation techniques. His educational background spans from Mavo to police academy training, including studies at Polizei Hochschule Hannover.
Poker Tournament Results
Stelwagen appeared in two Dutch poker tournaments reported by PokerCity in July 2011:
- €1,500 Tournament (325 entries, €500,679 prize pool): Stelwagen opened with 7♠7♥ from middle position and bet 14k on a flop of 4♣4♠J♦. He lost to Boelens' 8♠8♥ after a turn A and river 2, with both players checking down.
- €1,000 Tournament (128 entries, €128,000 prize pool): Stelwagen held the chip lead with 650,000 at three-handed, ahead of Nico Kostons (380k) and Dimitri van Leemt (234k).
These results suggest regular participation in European live events, though no major titles or WSOP cashes are recorded in available data.
Playing Style
Based on the reported hand, Stelwagen demonstrates a conservative-aggressive style: raising preflop with medium pocket pairs and continuing with a sizable bet on a dry flop. His check-down on later streets indicates caution in marginal spots. His deep run in the €1,000 event shows ability to accumulate chips and apply pressure.
Other Activities
Stelwagen's primary profession is as a police specialist, with over 39 years of experience in the National Police Corps. He holds skills in research, English, and operational coordination. Despite his poker pursuits, he maintains a low public profile, with no known nicknames or media interviews outside tournament reports.
Comments (0)
Sign in to join the discussion